Annotation Detail

Information
Associated Genes
TP53
Associated Variants
TP53 WILD TYPE
TP53 WILD TYPE
Associated Disease
cancer
Source Database
CIViC Evidence
Description
MDM2 Inhibitor screen in a panel of 260 cancer cell lines with well characterized TP53 status shows that only cancer cell lines with unaltered TP53 may be sensitive to MDM2 Inhibitor.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/2964
Gene URL
https://civic.genome.wustl.edu/links/genes/45
Variant URL
https://civic.genome.wustl.edu/links/variants/369
Rating
4
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Supports
Drug
AMGMDS3
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
25730903
Drugs
Drug NameSensitivitySupported
AMGMDS3Sensitivitytrue